Page last updated: 2024-11-06

divinyl benzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID66666
CHEMBL ID2133396
CHEBI ID189318
MeSH IDM0046235

Synonyms (41)

Synonym
o-divinylbenzene
1,2-divinylbenzene
diethenylbenzene
benzene, diethenyl-
1321-74-0
divinylbenzene
NCGC00090696-01
divinyl benzene
divinylbenzene [80%]
9003-69-4
CHEBI:189318
91-14-5
1,2-bis(ethenyl)benzene
AKOS006283068
einecs 202-043-2
unii-8z4w41dj9h
8z4w41dj9h ,
cas-1321-74-0
dsstox_cid_5216
dsstox_rid_77703
dsstox_gsid_25216
tox21_302792
NCGC00256471-01
FT-0689162
BP-20530
benzene, 1,2-diethenyl-
1,2-diethenylbenzene
divinyl benzen
divinyl-benzene
dvb
divinylbenzen
CHEMBL2133396
DTXSID30110005
divinylbenzene(80% active)
divinyl benzene(1cp(25 degrees c))
Q2324735
1,2-divinyl-benzene
A902046
?divinylbenzene
PD013422
amberlite(r) xad-1180

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of biotin to protein avidin was evaluated by a 4'-hydroxyazobenzene-2-carboxylic acid/avidin (HABA/avidin) binding assay and TEM."( Biotinylated thermoresponsive core cross-linked nanoparticles via RAFT polymerization and "click" chemistry.
Liu, L; Liu, Y; Luo, Y; Lv, W; Wang, X, 2011
)
0.37

Dosage Studied

ExcerptRelevanceReference
" A dose-response model was used to describe the breakthrough curves of the two ions at different initial concentrations."( A monolithic copolymer prepared from N-(4-vinyl)-benzyl iminodiacetic acid, divinylbenzene and N,N'-methylene bisacrylamide for preconcentration of cadmium(II) and cobalt(II) from biological samples prior to their determination by ICP-MS.
Chi, Q; Fang, H; Li, C; Li, M; Li, Q; Ma, H; Wang, M; Zhang, H, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
styrenes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency123.36600.000817.505159.3239AID1159527
pregnane X nuclear receptorHomo sapiens (human)Potency109.00200.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency39.01170.000229.305416,493.5996AID743069
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency66.82420.000627.21521,122.0200AID651741
Nuclear receptor ROR-gammaHomo sapiens (human)Potency0.23710.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (202)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (5.45)18.7374
1990's23 (11.39)18.2507
2000's52 (25.74)29.6817
2010's92 (45.54)24.3611
2020's24 (11.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.00 (24.57)
Research Supply Index5.36 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index95.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (60.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.47%)5.53%
Reviews5 (2.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.47%)0.25%
Other204 (96.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]